LA MARCA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.551
AS - Asia 13.332
EU - Europa 10.228
SA - Sud America 2.089
AF - Africa 314
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 19
Totale 56.615
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.968
SG - Singapore 4.353
CN - Cina 2.803
GB - Regno Unito 2.789
IT - Italia 2.074
HK - Hong Kong 1.953
BR - Brasile 1.615
VN - Vietnam 1.523
SE - Svezia 1.123
DE - Germania 876
FI - Finlandia 790
BD - Bangladesh 722
UA - Ucraina 594
RU - Federazione Russa 511
TR - Turchia 424
FR - Francia 401
CA - Canada 316
IN - India 289
KR - Corea 253
BG - Bulgaria 243
AR - Argentina 176
NL - Olanda 172
ID - Indonesia 170
JP - Giappone 138
MX - Messico 137
ES - Italia 120
IQ - Iraq 111
ZA - Sudafrica 87
EC - Ecuador 69
PK - Pakistan 69
PL - Polonia 66
RO - Romania 64
AU - Australia 62
CO - Colombia 60
AE - Emirati Arabi Uniti 59
PH - Filippine 59
IR - Iran 52
MY - Malesia 49
IE - Irlanda 48
CL - Cile 47
VE - Venezuela 46
UZ - Uzbekistan 45
DZ - Algeria 42
MA - Marocco 42
LT - Lituania 39
BE - Belgio 37
CH - Svizzera 36
DK - Danimarca 35
CZ - Repubblica Ceca 33
AT - Austria 32
KE - Kenya 32
EG - Egitto 30
PY - Paraguay 29
TW - Taiwan 29
SA - Arabia Saudita 26
TH - Thailandia 26
JO - Giordania 24
NP - Nepal 24
JM - Giamaica 22
AL - Albania 20
CR - Costa Rica 20
TN - Tunisia 20
DO - Repubblica Dominicana 17
NZ - Nuova Zelanda 17
PE - Perù 17
AZ - Azerbaigian 16
BO - Bolivia 16
HN - Honduras 16
KZ - Kazakistan 16
HR - Croazia 15
IL - Israele 15
NG - Nigeria 15
NO - Norvegia 14
LV - Lettonia 12
MD - Moldavia 12
PS - Palestinian Territory 12
PT - Portogallo 11
GR - Grecia 10
HU - Ungheria 10
UY - Uruguay 10
GT - Guatemala 9
PA - Panama 9
ET - Etiopia 8
NI - Nicaragua 8
OM - Oman 8
PR - Porto Rico 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
BA - Bosnia-Erzegovina 7
EU - Europa 7
GH - Ghana 7
QA - Qatar 7
KW - Kuwait 6
LB - Libano 6
SC - Seychelles 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
MN - Mongolia 5
RS - Serbia 5
Totale 56.514
Salva come PNG Salva come JPEG
Città #
Fairfield 3.903
Ashburn 3.283
Singapore 2.716
Santa Clara 2.415
Hong Kong 1.908
Woodbridge 1.886
Southend 1.737
Houston 1.588
Seattle 1.478
Cambridge 1.307
Wilmington 1.174
Chandler 1.125
Jacksonville 906
San Jose 784
Ann Arbor 759
Dearborn 681
Helsinki 679
Nyköping 675
Beijing 634
London 622
Hefei 590
Ho Chi Minh City 489
Los Angeles 441
Council Bluffs 410
Modena 397
The Dalles 375
Chicago 373
Hanoi 337
New York 329
San Diego 290
Princeton 238
Sofia 234
Milan 232
Seoul 212
Izmir 207
Lauterbourg 194
Eugene 193
Moscow 185
Boardman 173
Buffalo 170
Dallas 153
São Paulo 141
Shanghai 138
Rome 121
Bremen 119
Jakarta 112
Salt Lake City 112
Tokyo 94
Munich 87
Guangzhou 86
Phoenix 82
Bologna 79
Frankfurt am Main 77
Da Nang 73
Atlanta 72
Tampa 69
Redwood City 68
Redondo Beach 65
Haiphong 64
Amsterdam 63
Columbus 62
Orem 61
Toronto 61
Vancouver 59
Montreal 53
Rio de Janeiro 50
Denver 47
Naples 46
Baghdad 44
Elk Grove Village 44
Warsaw 44
Chennai 43
Dublin 43
Johannesburg 43
Mexico City 41
Falls Church 40
San Francisco 40
Norwalk 39
Tashkent 39
Winnipeg 39
Biên Hòa 38
Brooklyn 38
Miano 37
Stockholm 37
Kilburn 34
Nanjing 34
Melbourne 33
Fremont 32
Philadelphia 32
Belo Horizonte 31
Iasi 31
Ankara 30
Brasília 29
Florence 29
Mumbai 29
Newark 29
Boston 28
Kunming 28
Porto Alegre 28
Turin 28
Totale 39.777
Salva come PNG Salva come JPEG
Nome #
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial 643
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). 504
Anti-Mullerian hormone (AMH): what do we still need to know? 478
Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome 463
Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period 439
The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study 437
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 434
MATER protein as substrate of PKCepsilon in human cumulus cells. 419
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach 413
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice 393
The complex relationship between female age and embryo euploidy 386
Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. 367
Age-specific nomogram for the decline in antral follicle count throughout the reproductive period 367
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 364
From a circle to a sphere: the ultrasound imaging of ovarian follicle with 2D and 3D technology 355
Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles 348
Human ovarian tissue cryopreservation: effect of sucrose concentration on morphological features after thawing 345
A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos 344
Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium 343
How Much Does AMH Really Vary in Normal Women? 341
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria 338
The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH 337
Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? 332
FSHR polymorphism p.N680S mediates different responses to FSH in vitro 331
Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol 329
Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period 328
Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology 327
Adnexal torsion during pregnancy after oocyte in vitro maturation and intracytoplasmic sperminjection cycle 323
Pregnant woman infected by Coronavirus disease (COVID-19) and calcifications of the fetal bowel and gallbladder 322
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles 321
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 321
Vitamin D and ovarian reserve: making clinical decisions 319
Elevated levels of nitrous dioxide are associated with lower AMH levels: A real-world analysis 316
Nitric Oxide concentration in endometrial washing throughout the menstrual cycle 313
Periodontal disease and nitric oxide levels in low risk women with preterm labor 312
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization 312
Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium 308
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome 306
Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study 302
Primary ovarian insufficiency: autoimmune causes. 301
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 300
Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study 300
The physiology and clinical utility of anti-Mullerian hormone in women 296
The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro 295
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count 295
A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles 294
The management of vaginal agenesis: report of 104 cases 294
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction 292
New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation 292
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 290
Seminal plasma total antioxidant capacity and semen parameters in patients with varicocele 287
Administration of L-thyroxine does not improve the response of the hypothalamo-pituitary-ovarian axis to clomiphene citrate in functional hypothalamic amenorrhea 286
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? 285
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 285
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 285
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro 283
Anti-Mullerian hormone concentrations in maternal serum during pregnancy 280
Adrenal adenocarcinoma and empty sella syndrome in a 37-year-old woman 280
The use of ovarian reserve markers in IVF clinical practice: a national consensus 275
Gonadotrophins modulate cell death-related genes expression in human endometrium 275
Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in PCOS patients 275
Utero-vaginal anastomosis in the treatment of cervical atresia 274
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history 274
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 273
The ovarian follicular pool and reproductive outcome in women. 271
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: An individual patient data meta-analysis 269
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation 265
Anti-mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause 265
Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes 264
Metformin treatment of PCOS during adolescence and the reproductive period 261
How to personalize ovarian stimulation in clinical practice 261
Rectus abdominis muscle endometriosis: Case report and review of the literature 261
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 258
Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction 257
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI) 255
Rectovaginal fistula repair using fascia graft of autologous abdominal muscles 254
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study 252
The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age 252
Serum anti-Mullerian hormone throughout the human menstrual cycle 250
Reply: The two sides of the individualization of controlled ovarian stimulation 250
8th World Congress of Gynecological Endocrinology 250
Anti-Müllerian hormone: clairvoyance or crystal clear? 246
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia 244
Thyroid function in early pregnancy II: Paradoxical growth hormone response to thyrotropin-releasing hormone 243
Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome 242
How adenomyosis changes throughout pregnancy: A retrospective cohort study 242
External validation of anti-Müllerian hormone based prediction of live birth in assisted conception 241
Soluble L-selectin levels during controlled ovarian hyperstimulation 241
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 241
Hormonal and ultrasound markers of ovarian function in a woman with a balanced 1;11 translocation 240
Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply 239
Progestin effects on epidermal growth factor receptor (EGFR) endometrial expression in normal and hyperplastic endometrium 239
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 239
Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy 238
Ultrastructural and DNA fragmentation analyses in swim-up selected human sperm 238
Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency 238
The negative impact of most relevant infections on fertility and Assisted Reproduction Technology 238
T-shaped uterus: What has been done, what should be done 238
Recombinant human leptin in women with hypothalamic amenorrhea. 236
The journey from the old to the new AMH assay: how to avoid getting lost in the values 236
Totale 30.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.566 176 862 513 160 84 175 345 216 415 356 872 392
2022/20233.625 454 416 349 293 473 434 82 308 414 39 174 189
2023/20243.007 95 153 122 270 479 180 510 456 68 95 131 448
2024/20258.209 260 89 107 581 1.510 1.099 434 449 1.158 519 786 1.217
2025/202618.625 1.057 530 1.581 2.000 2.208 1.427 2.410 1.109 1.884 1.583 1.490 1.346
2026/20271.059 1.059 0 0 0 0 0 0 0 0 0 0 0
Totale 57.056